Related Experiment Videos

A streptomycin dependent live Pasteurella multocida vaccine for the prevention of rabbit pasteurellosis

Laboratory Animal Science
|June 1, 1980
PubMed

Insights

A novel streptomycin-dependent Pasteurella multocida mutant was developed as a live vaccine. Vaccination via intranasal or subcutaneous routes completely protected rabbits against respiratory pasteurellosis.

Area of Science:

  • Veterinary Medicine
  • Microbiology
  • Immunology

Background:

  • Pasteurella multocida causes respiratory pasteurellosis in rabbits.
  • Developing effective vaccines is crucial for controlling rabbit respiratory diseases.

Purpose of the Study:

  • To develop and evaluate a live streptomycin-dependent Pasteurella multocida vaccine for rabbits.
  • To assess the efficacy of intranasal and subcutaneous vaccination routes.

Main Methods:

  • Isolation of Pasteurella multocida from infected rabbits.
  • Induction of streptomycin dependence using N-methyl-N'-nitro-N-nitrosoguanidine.
  • Vaccination of healthy rabbits via intranasal or subcutaneous routes.
  • Challenge with wild-type Pasteurella multocida.

Main Results:

  • A streptomycin-dependent mutant of Pasteurella multocida was successfully generated.
  • Both intranasal and subcutaneous vaccination provided complete protection against homologous challenge.
  • Vaccinated rabbits showed no clinical signs, gross pathology, or organism recovery.

Conclusions:

  • A live, streptomycin-dependent Pasteurella multocida vaccine is effective in preventing respiratory pasteurellosis in rabbits.
  • Intranasal and subcutaneous administration routes are both viable for vaccination.
  • This vaccine represents a promising tool for controlling pasteurellosis in rabbit populations.

Related Concept Videos